Is a complete FRA/DTC research report available?

No complete published report is available for fra/DTC (FRA/DTC) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

FRA/DTC (FRA/DTC)

Frankfurt Stock Exchange: FRA/DTC · EUR

€0.23

-0.00 (-0.9%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first FRA/DTC analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	18.3M
Net income (ttm)	-3.8M
EPS (ttm)	-€0.06
Volume	0

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -3.8M
EPS (ttm): -€0.06
Market cap: 18.3M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

All FRA/DTC indicators

Market & fundamental data

Available fields

135

Groups with data

Currency

CAD

Showing 135 of 135 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	DE
Enterprise value	EUR 17.5M
Exchange	Frankfurt Stock Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-07-31
Market cap	EUR 18.3M
Price	EUR 0.23
Price currency	EUR
Sic	2836
Symbol	fra/DTC
Website	https://defencetherapeutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-20.51%
FCF yield	-15.42%
P/B ratio	5.45x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	EUR -3.8M
ROA	-40.06
Roa5y	-193.2
ROCE	-44.67
ROE	-232.8
ROIC	-58.04

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-42.59%
Cagr3y	-50.75%
Cagr5y	-44.43%

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	EUR 5.9M
Cash	EUR 1.8M
Current Assets	EUR 2M
Current Liabilities	EUR 603,019
Debt	EUR 971,900
Debt Equity	EUR 0.29
Debt FCF	EUR -0.34
Equity	EUR 3.4M
Interest Coverage	-13.06
Liabilities	EUR 2.5M
Long Term Assets	EUR 3.8M
Long Term Liabilities	EUR 1.9M
Net Cash	EUR 862,897
Net Cash By Market Cap	EUR 4.71
Net Cash Growth	102.11%
Net Debt Equity	EUR -0.26
Tangible Book Value	EUR 3.4M
Tangible Book Value Per Share	EUR 0.04

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.37
Net Working Capital	EUR -402,712
Quick ratio	3.36
Working Capital	EUR 1.4M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-34.05%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-42.57%
200-day SMA	0.37
3Y total return	-88.06%
50-day SMA	0.27
50-day SMA vs 200-day SMA	50under200
5Y total return	-94.7%
All Time High	5.76
All Time High Change	-96.04%
All Time High Date	2021-06-18
All Time Low	0.19
All Time Low Change	20%
All Time Low Date	2026-07-24
ATR	0.02
Ch YTD	-45.71
High	0.27
High52	0.59
High52 Date	2025-12-05
High52ch	-61.62%
Low	0.23
Low52	0.19
Low52 Date	2026-07-24
Low52ch	20%
Ma50ch	-16.08%
Price vs 200-day SMA	-38.87%
RSI	45.2
RSI Monthly	32.23
RSI Weekly	33.75
Sharpe ratio	0.35x
Sortino ratio	0.6
Total Return	-34.05%
Tr YTD	-45.71
Tr1m	-20.28%
Tr1w	-3.39%
Tr3m	-27.39%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -2.4M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	67,946,153%
Net Borrowing	1,227,258.6
Shares Insiders	10.35%
Shares Qo Q	6.65%
Shares Yo Y	34.05%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -3M
Adjusted OCF	-3,038,130
Average Volume	7,662.05x
Bv Per Share	0.04
CAPEX	EUR -9,354
Ch1m	-20.28
Ch1w	-3.39
Ch1y	-42.57
Ch3m	-27.39
Ch3y	-88.06
Ch5y	-94.7
Ch6m	-45.71
Change	-0.87%
Change From Open	-0.87
Close	0.23
Days Gap	0
Depreciation Amortization	12,911.5
Earnings Date	2026-10-28
EBIT	EUR -2.4M
EBITDA	EUR -2.3M
EPS	EUR -0.06
F Score	2
FCF	EUR -2.8M
FCF EV Yield	-16.18x
Financing CF	3,378,062
Fiscal Year End	June
Founded	2,017
Investing CF	-18,672
Is Primary Listing	0
Last Earnings Date	2026-02-23
Last Report Date	2026-03-31
Ma150	0.33
Ma150ch	-31.3%
Ma20	0.24
Ma20ch	-5.43%
Net CF	542,628
Next Earnings Date	2026-10-28
Open	0.23
Position In Range	0
Ppne	103,904.6
Price Date	2026-07-30
Ptbv Ratio	5.45
Relative Volume	1.42x
Share Based Comp	221,369
Tr6m	-45.71%
Volume	0

FRA/DTC (FRA/DTC)

Coverage state: Market snapshot only — no published research

Generate the first FRA/DTC analysis

Price

Financial snapshot

Fair-value bridge

Latest news · FRA/DTC

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All FRA/DTC indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on FRA/DTC

Frequently asked questions